nebrhahe53
Very helpful member
- Joined
- Jun 13, 2014
- Messages
- 1,017
- Reason
- PALS
- Diagnosis
- 06/2014
- Country
- US
- State
- Tx
- City
- Austin
Janie, I read the average lifespan for someone with als is 1000 days from diagnosis something like 2.5 years. So if riluzole extends life by 10% that is just about 2-3 months. Of course what part of that lifespan is extended. The part where you have to be hoisted to the rest room and become incontinent... Well I could do without that life extension.
I think there are better drugs now but the FDA won't let us use them. Nuedexta, which I am taking for " pseudo bulbar effect" has allowed me to eat for 8 more months and who knows if that's why I can still talk normally.
But insurance won't pay for any drug the FDA doesn't certify. For people in our situation the FDA should let us be guinea pigs if we choose. If I have to die, I'd at least like to make the death meaningful by contributing to science.
By the way my career was to construct statistically significant experiments, and in systems a lot less challenging than the human body.
If I had ever proposed a 2 year experiment with 15-20 data cells I would have been laughed out of the room, and then justifiably fired. It's no wonder stage 2 trials don't work in stage 3, you need a lot more stage 2 data. This is why essentially no progress has been made in als for 20 years.
I think there are better drugs now but the FDA won't let us use them. Nuedexta, which I am taking for " pseudo bulbar effect" has allowed me to eat for 8 more months and who knows if that's why I can still talk normally.
But insurance won't pay for any drug the FDA doesn't certify. For people in our situation the FDA should let us be guinea pigs if we choose. If I have to die, I'd at least like to make the death meaningful by contributing to science.
By the way my career was to construct statistically significant experiments, and in systems a lot less challenging than the human body.
If I had ever proposed a 2 year experiment with 15-20 data cells I would have been laughed out of the room, and then justifiably fired. It's no wonder stage 2 trials don't work in stage 3, you need a lot more stage 2 data. This is why essentially no progress has been made in als for 20 years.